NasdaqCM - Nasdaq Real Time Price USD

Arcadia Biosciences, Inc. (RKDA)

Compare
5.07
+0.01
+(0.20%)
At close: January 16 at 4:00:00 PM EST
5.01
-0.06
(-1.18%)
After hours: January 16 at 6:35:33 PM EST
Loading Chart for RKDA
DELL
  • Previous Close 5.06
  • Open 4.88
  • Bid --
  • Ask --
  • Day's Range 4.38 - 5.10
  • 52 Week Range 1.85 - 10.31
  • Volume 60,007
  • Avg. Volume 1,254,946
  • Market Cap (intraday) 6.92M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -6.77
  • Earnings Date Mar 26, 2025 - Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.00

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

www.arcadiabio.com

21

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RKDA

View More

Performance Overview: RKDA

Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

RKDA
16.06%
S&P 500
0.51%

1-Year Return

RKDA
91.32%
S&P 500
24.11%

3-Year Return

RKDA
87.69%
S&P 500
27.33%

5-Year Return

RKDA
97.51%
S&P 500
80.51%

Compare To: RKDA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RKDA

View More

Valuation Measures

Annual
As of 9/19/2024
  • Market Cap

    6.92M

  • Enterprise Value

    690.25k

  • Trailing P/E

    --

  • Forward P/E

    36.63

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.26

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    0.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -112.43%

  • Return on Assets (ttm)

    -38.72%

  • Return on Equity (ttm)

    -52.65%

  • Revenue (ttm)

    5.18M

  • Net Income Avi to Common (ttm)

    -6.72M

  • Diluted EPS (ttm)

    -6.77

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.58M

  • Total Debt/Equity (mrq)

    3.41%

  • Levered Free Cash Flow (ttm)

    -7.37M

Research Analysis: RKDA

View More

Company Insights: RKDA

Research Reports: RKDA

View More

People Also Watch